Q4 details
Sales SEK 346m (-3% vs ABGSCe 356m, 4% vs cons 333m). EBIT SEK 62m (-23% vs ABGSCe 81m, -10% vs cons 69m). EBIT margin 18.0% (ABGSCe 22.7%, cons 20.7%). Adj. EBIT 69m (SEK 7m impairment), in line with cons, adj. EBIT margin 20.0%. Order intake SEK 298m (19% vs ABGSCe 250m, 7% vs cons 278m).
